Note: Preliminaries -- Contents -- Preface -- Chapter 1 Transfer Functions and Spectral Models -- Chapter 2 State Space Representation -- Chapter 3 Discrete Time Systems -- Chapter 4 Structural Properties of Linear Systems -- Chapter 5 Signals Deterministic and Statistical Models -- Chapter 6 Kalman's Formalism for State Stabilization and Estimation -- Chapter 7 Process Modeling -- Chapter 8 Simulation and Implementation of Continuous Time Loops -- Chapter 9 Analysis by Classic Scalar Approach -- Chapter 10 Synthesis of Closed Loop Control Systems -- Chapter 11 Robust Single Variable Control through Pole Placement -- Chapter 12 Predictive Control -- Chapter 13 Methodology of the State Approach Control -- Chapter 14 Multi variable Modal Control -- Chapter 15 Robust H LMI Control -- Chapter 16 Linear Time Variant Systems -- List of Authors -- Index.

Note: Intro -- MOLECULAR PROPERTIES OF DRUG RECEPTORS -- Contents -- Chairman's opening remarks -- Receptors as defined by their pharmacological properties -- Discussion -- The cholinergic receptor in skeletal muscle -- Discussion -- Adenyl cyclase as a component of the adrenergic receptor -- Discussion -- On receptors in the postsynaptic membrane of the motor end plate -- Discussion -- General Discussion -- Crystallographic studies of the active site of lysozyme -- Discussion -- Nuclear magnetic resonance studies of protein binding sites: the complex of staphylococcal nuclease with 3'.5'-thymidine diphosphate -- Discussion -- Fluorescent probes of biological macromolecules -- Discussion -- General Discussion -- The interaction of the subunits of haemoglobin as a mechanism of control -- Discussion -- Conformational transitions in the course of membrane excitation -- Discussion -- General Discussion -- Affinity labelling of protein active sites -- Discussion -- Counting acetylcholine receptors in the electroplax -- Discussion -- The nature of complex formation -- Discussion -- Final Discussion -- Author index -- Subject index.

Note: Intro -- Silicon Carbide: Volume 2: Power Devices and Sensors -- Contents -- Preface -- List of Contributors -- Volume 2 Silicon Carbide: Power Devices and Sensors -- Part A View from Industry -- 1 Present status and future prospects for electronics in electric vehicles/hybrid electric vehicles and expectations for wide-bandgap semiconductor devices -- 1.1 Issues surrounding automobiles -- 1.2 Past, present, and future of Toyota hybrid vehicles -- 1.3 Newest hybrid vehicle -- 1.4 Expectations for wide-bandgap semiconductors in HV inverter applications -- 1.5 Toyota Group research and development on wide-bandgap semiconductor devices -- 1.6 Conclusions -- References -- 2 Silicon carbide power-device products - Status and upcoming challenges with a special attention to traditional, nonmilitary industrial applications -- 2.1 Introduction -- 2.2 SiC in power electronics -- 2.3 Summary -- References -- Part B I Unipolar Devices Schottky Diodes -- 3 Effect of an intermediate graphite layer on the electronic properties of metal/SiC contacts -- 3.1 Introduction -- 3.2 Experimental -- 3.3 Results -- 3.4 Discussion -- 3.5 Conclusions -- References -- 4 Reliability aspects of SiC Schottky diodes -- 4.1 Introduction -- 4.2 Micropipes -- 4.3 Avalanche ruggedness by design improvement -- 4.4 Product improvement by high performance die attach -- 4.5 Reliability test results -- 4.6 Summary -- References -- Part B II JFET -- 5 Design, process, and performance of all-epitaxial normally-off SiC JFETs -- 5.1 Introduction -- 5.2 Advantages of the SiC JFET technology -- 5.3 All-epitaxial normally-off SiC DGTJFET design -- 5.4 Innovative device process technologies -- 5.5 All-epitaxial 1200 V trench 4H-SiC DGTJFET -- 5.6 Conclusion -- References -- 6 Extreme temperature 6H-SiC JFET integrated circuit technology -- 6.1 Introduction -- 6.2 Transistors -- 6.3 Circuits. , 6.4 Summary & -- future work -- References -- 7 1200 V SiC vertical-channel-JFETs and cascode switches -- 7.1 Introduction -- 7.2 Large-area 1200 V 4H-SiC vertical JFET structures -- 7.3 Investigation of the suitability of 1200 V normally-off vertical-channel SiC JFETs for power switching applications -- 7.4 1200 V normally-off all-SiC VJFET based cascode switch -- 7.5 Reliability of the 1200 V normally-off all-SiC VJFET cascode switch -- 7.6 Thermal properties of VJFET/cascode -- 7.7 0.143 cm2 active-area 1200 V class vertical-channel JFETs -- 7.8 Edge termination of large-area vertical-channel JFETs -- 7.9 Summary -- References -- Part B III MOS Interfaces -- 8 Alternative techniques to reduce interface traps in n-type 4H-SiC MOS capacitors -- 8.1 Introduction -- 8.2 Material, processing parameters, and analysis techniques -- 8.3 Thermal oxidation in a tungsten lamp furnace combined with a microwave plasma -- 8.4 Over-oxidation of N-implanted 4H-SiC -- 8.5 Over-oxidation of N-/Al-implanted 4H-SiC -- 8.5.1 Material and implantation parameters -- 8.5.2 Results and discussion -- 8.6 Summary -- References -- 9 High electron mobility achieved in n-channel 4H-SiC MOSFETs oxidized in the presence of nitrogen -- 9.1 Introduction -- 9.2 Experimental -- 9.3 Results -- 9.4 Discussion -- 9.5 Summary -- References -- 10 4H-SiC MISFETs with nitrogen-containing insulators -- 10.1 Introduction -- 10.2 Survey of "nitridation" -- 10.3 Device fabrication -- 10.4 Characteristics of MIS capacitors and FETs on 4H-SiC(0001) -- 10.5 Characteristics of MIS capacitors and FETs on 4H-SiC(0001) -- 10.6 Influence of effective fixed charge density on channel mobility -- 10.7 Application of N-containing insulators to p-channel MIS capacitors and FETs -- 10.8 Summary of effects of N-Containing insulators on n- and p-type SiC MIS capacitors and FETs -- 10.9 Conclusion. , References -- 11 Inversion layer electron transport in 4H-SiC metal-oxide-semiconductor field-effect transistors -- 11.1 Introduction -- 11.2 Silicon MOS history -- 11.3 4H-silicon carbide MOS mobility characterization -- 11.4 Physical characterization of the interface -- 11.5 Differences between inversion layer electron transport in Si MOS and 4H-SiC MOS -- 11.6 Future work -- 11.7 Summary -- References -- Part C MOSFET and JFET Power Devices -- 12 Development of SiC diodes, power MOSFETs and intelligent power modules -- 12.1 Introduction -- 12.2 SiC diodes -- 12.3 SiC MOSFETs -- 12.4 SiC trench MOSFETs -- 12.5 SiC IPMs -- 12.6 Summary -- References -- 13 Reliability issues of SiC power MOSFETs toward high junction temperature operation -- 13.1 Introduction -- 13.2 Issues and measures for high Tj operation -- 13.3 Device structure and process integration -- 13.4 Discussion -- 13.5 Conclusion -- References -- 14 Application of silicon carbide transistors in photovoltaic - inverters -- 14.1 Introduction -- 14.2 Photovoltaic trend -- 14.3 Photovoltaic systems -- 14.4 Normally-off SiC-JFETs -- 14.5 SiC-MOSFETs -- 14.6 SiC-FETs as synchronous rectifiers -- 14.7 Single phase inverter with normally-off SiC-JFETs -- 14.8 Three phase full bridge inverter with SiC-MOSFETs -- 14.9 Production costs of PV-inverters -- 14.10 Financial benefits with SiC-transitors -- 14.11 Conclusions and outlook -- Appendix: measurement setup -- References -- Part D Bipolar Devices -- 15 Design and technology considerations for SiC bipolar devices: BJTs, IGBTs, and GTOs -- 15.1 SiC bipolar junction transistors -- 15.2 SiC insulated gate bipolar transistors -- 15.3 SiC Gate turn-off thyristors -- 15.4 Technical challenges in SiC bipolar devices -- 15.5 Summary -- References. , 16 Suppressed surface-recombination structure and surface passivation for improving current gain of 4H-SiC BJTs -- 16.1 Introduction -- 16.2 Survey of the conventional BJTs with high common emitter current gain -- 16.3 Basic structure and operating principle of the proposed BJTs -- 16.4 Evaluation of surface passivation for improving current gain -- 16.5 Design and fabrication of the SSR-BJTs -- 16.6 Characteristics of the SSR-BJTs -- 16.7 Conclusion -- References -- 17 SiC avalanche photodiodes and photomultipliers for ultraviolet and solar-blind light detection -- 17.1 Introduction -- 17.2 Silicon carbide avalanche photodiodes -- 17.3 Influence of defects in SiC substrate on device performance -- 17.4 Silicon carbide photomultiplier -- 17.5 Summary -- References -- Index.

Note: Intro -- Contents -- Preface -- 1. Introduction -- 2. Early History and the Struggle for Resources: Native Nations, Spain, Mexico, and the United States -- 3. The Valley of the Heart's Delight: Santa Clara County's Agricultural Period, 1870-1970 -- 4. The Emergence of Silicon Valley: High-Tech Development and Ecocide, 1950-2001 -- 5. The Political Economy of Work and Health in Silicon Valley -- 6. The Core: Work and the Struggle to Make a Living without Dying -- 7. The Periphery: Expendable People, Dangerous Work -- 8. Beyond Silicon Valley: The Social and Environmental Costs of the Global Microelectronics Industry -- 9. Toward Environmental and Social Justice in Silicon Valley, USA, and Beyond -- 10. The Broader Picture: Natural Resources, Globalization, and Increasing Inequality -- Notes -- References -- Index -- About the Authors.

Note: Intro -- Contents -- Preface and Acknowledgements -- Prologue: The Land and the Peoples -- 1. Wealth and Value in a Changing World -- 2. Land-based Stories of Peoples and Home Places -- 3. A Kincentric Approach to Nature -- 4. Honouring Nature through Ceremony and Ritual -- 5. The Balance between Humans and Nature -- 6. Looking After the Lands and Waters -- 7. Everything Is One -- 8. Finding Meaning in a Contemporary Context -- Source Notes -- References -- Index.

Note: Heilende Magnete - strahlende Handys -- Copyright Page -- Inhalt -- Vorwort -- 1 Vom Mythos des Unsichtbaren - eine Einleitung -- Das magnetische Feld -- 2 Von der Entdeckung der magnetischen Kraft bis zum »animalischen Magnetismus« des Franz Anton Mesmer -- 3 Gibt es tatsächlich einen animalischen Magnetismus? -- 4 Die unendliche Geschichte vom magnetisierten Wasser -- 5 Können sich Tiere im magnetischen Feld der Erde orientieren? -- 6 Der Mensch im geomagnetischen Feld -- 7 Kann man mit Magneten heilen? -- 8 An den Grenzen maximaler magnetischer Feldstärken -- Das elektrische Feld -- 9 Von der »Venus electrificata« bis zur Entdeckung der »thierischen Elektrizität« -- 10 Die Zelle als Generator und Akkumulator elektrochemischer Energie -- 11 Das elektrische Kommunikationssystem im Körper -- 12 Felder und Ströme im Körper -- 13 Elektrische Felder in Diagnostik und Therapie -- 14 Elektro-Ökologie - die elektrische Kommunikation der Tiere im Wasser -- 15 Vom Blitz und anderen Entladungen -- Elektromagnetische Schwingungen und Pulse -- 16 Von Schwingungen bis zum Quantenschauer - das Spektrum elektromagnetischer Wellen und Strahlung im Überblick -- 17 Wetterfühligkeit durch Luftelektrizität und Atmospherics? -- 18 Das elektromagnetische Feld aus dem Stromnetz - erzeugt das Heizkissen Krebs? -- 19 Pulse, Schwingungen und Mikrowellen in Diagnostik und Therapie -- 20 Vom Mobilfunk zur Biotechnologie - HF-Felder in der Technik und um uns -- 21 Beeinflussen uns physikalisch nicht erfassbare Strahlen und Felder? -- Wissenschaft, Parawissenschaft und Psi-Forschung -- 22 Bio-Elektromagnetismus - eine Spielwiese für Phantasten? -- Literaturverzeichnis -- Namens-und Sachverzeichnis.

Note: Intro -- VORWORT -- I. THEORIE UND METHODOLOGIE -- Das Genfer Modell zur Gesprächsanalyse -- Zur Beschreibung der Dialogdynamik. Plädoyer für eine kom¬munikationshistorische Betrachtungsweise -- Einige Anmerkungen (und Wiederholungen) zu Fragen der Methodologie von Kommunikationstypologie -- Formen der Einbettung von Dialogwiedergaben in Erzähl¬texten -- HANDELN und AUSHANDELN. Einige grundsätzliche Anmerkungen zur Dialoganalyse -- Dialogues: How basic are they? -- Regeln und Dialogeinheiten -- Dynamics of dialogue -- Repetition und Assoziation in der Gesprächsent¬wicklung -- II. TYPOLOGIE -- Le lieu et le sens du dialogue philosophique -- Controversies as quasi-dialogues -- Medienspezifische Dialogsorten. Überlegungen zu ihrer Klassifizierung und Beschreibung -- Dialogsorten: Mediengespräche -- Dialog ohne Sprecherwechsel? Anmerkungen zur inter¬nen Dialogizität monologischer Texte -- III. UNTERWEISUNG -- Instruktionen in der betrieblichen Ausbildung. Analyse typischer Probleme bei der kommunikativen Vermittlung fachlicher Kenntnisse und Fertigkeiten -- Der maieutische Unterweisungsdialog -- Typologische Aspekte von Unterrichtsgesprächen -- Grundzüge des Handlungsspiels UNTERWEISEN -- IV. MUSTERBESCHREIBUNGEN -- Das Verhältnis von Wissen und sprachlichem Handeln am Beispiel des Erzählens -- Zeitungen und Leser im Dialog. Ein Beitrag zur kommunikativen Analyse von Pressetexten -- Dialogische Strukturen juristischer Gebrauchstexte -- Bist du katholisch? - Intervention oder Unterbrechung in einem psychoanalytischen Gespräch -- Dialoggrammatische Beschreibung psychotherapeutischer Kommunikation. Vertiefende Interventionen im gestalttherapeuti¬schen Gespräch -- Leserbezug und dialogische Techniken in Software¬handbüchern -- Salongespräche - Kommunikationen beim Coiffeur. , Von Hasenbraten und Lammkoteletten. Überlegungen zum Funktionieren schriftlicher Anweisungstexte, zum Beispiel Kochrezepte -- Genres de discours et types de dialogue: le "talk-show -- RATGEBEN. Am Beispiel der Sendereihe "Von Mensch zu Mensch" (BR) -- Verhaltensambivalenzen im Zugangsdisplay. Vergleichen¬de Betrachtungen zu spontanen Straßendiskussionen und dem Sozialverhalten nichtmenschlicher Primaten -- 'The art of talking about nothing'. Zur Be¬schreibung phatischer Dialoge -- Gesprächstyp Blödeln -- Kommunikation mit einem geistigbehinderten Kind im Unterricht -- VERZEICHNIS DER REFERENTEN.

Note: Front Cover -- Magnetic Resonance in Epilepsy -- Copyright Page -- Contents -- List of contributors -- Editors -- Foreword -- Preface to the Second Edition -- Acknowledgments -- Chapter 1. Introduction to epilepsy -- Chapter 2. Principles of magnetic resonance imaging -- Chapter 3. Brain anatomy -- Chapter 4. Temporal lobe epilepsy -- Chapter 5. Extra-temporal lobe epilepsy -- Chapter 6. MRI in special conditions associated with epilepsy -- Chapter 7. Malformations of cortical development -- Chapter 8. Structural analysis applied to epilepsy -- Chapter 9. Imaging and neuropsychology -- Chapter 10. Functional MRI in epilepsy -- Chapter 11. Magnetic resonance neurophysiology: simultaneous EEG and fMRI -- Chapter 12. MR diffusion and perfusion imaging in epilepsy -- Chapter 13. Magnetic resonance spectroscopy -- Chapter 14. Single-photon-emission computed tomography in epilepsy -- Chapter 15. Positron-emission tomography in epilepsy -- Chapter 16. Magnetoencephalography in epilepsy -- Index.

Note: Volume 1 -- Front Cover -- Meyler's Side Effects of Drugs: The International Encyclopedia of Adverse Drug Reactions and Interactions -- Copyright Page -- Table of Contents -- Contributors -- Foreword -- Preface -- How to use this book -- Alphabetical list of drug monographs -- PART A: -- Chapter 1. Abacavir -- General Information -- Organs and Systems -- References -- Chapter 2. Abciximab -- General Information -- Organs and Systems -- Susceptibility Factors -- References -- Chapter 3. Abecarnil -- General Information -- References -- Chapter 4. Abetimus -- General Information -- References -- Chapter 5. Acamprosate -- General Information -- Organs and Systems -- References -- Chapter 6. Acebutolol -- General Information -- Organs and Systems -- Drug Administration -- References -- Chapter 7. Acecainide -- General Information -- Organs and Systems -- Susceptibility Factors -- Monitoring Drug Therapy -- References -- Chapter 8. Aceclofenac -- General Information -- Organs and Systems -- Reference -- Chapter 9. Acemetacin -- General Information -- Reference -- Chapter 10. Acetylcholinesterase inhibitors -- General Information -- Organs and Systems -- Second-Generation Effects -- Susceptibility Factors -- Drug-Drug Interactions -- References -- Chapter 11. Acetylcysteine -- General Information -- Organs and Systems -- Drug-Drug Interactions -- References -- Chapter 12. Acetylsalicylic acid -- General Information -- Organs and Systems -- Long-Term Effects -- Second-Generation Effects -- Susceptibility Factors -- Drug Administration -- Drug-Drug Interactions -- Food-Drug Interactions -- Interference with Diagnostic Tests -- References -- Chapter 13. Aciclovir -- General Information -- Organs and Systems -- Second-Generation Effects -- Drug Administration -- References -- Chapter 14. Acipimox -- General Information -- Organs and Systems -- References. , Chapter 15. Acivicin -- General Information -- References -- Chapter 16. Acoraceae -- General Information -- References -- Chapter 17. Acrisorcin -- General Information -- Reference -- Chapter 18. Acrivastine -- General Information -- Organs and Systems -- References -- Chapter 19. Acrylic bone cement -- General Information -- Organs and Systems -- References -- Chapter 20. Activated charcoal -- General Information -- Organs and Systems -- References -- Chapter 21. Adefovir -- General Information -- Organs and Systems -- References -- Chapter 22. Ademetionine -- General Information -- Reference -- Chapter 23. Adenosine and adenosinetriphosphate (ATP) -- General Information -- Organs and Systems -- Drug Administration -- Drug-Drug Interactions -- Diagnosis of Adverse Drug Reactions -- References -- Chapter 24. Adiphenine -- General Information -- Chapter 25. Adrenaline -- General Information -- Organs and Systems -- Susceptibility Factors -- Drug Administration -- Drug-Drug Interactions -- References -- Chapter 26. Adrenoceptor agonists -- General Information -- Chapter 27. Ajmaline and its derivatives -- General Information -- Organs and Systems -- Drug Administration -- References -- Organs and Systems -- Chapter 28. Alatrofloxacin and trovafloxacin -- General Information -- Organs and Systems -- Second-Generation Effects -- Susceptibility Factors -- Monitoring Therapy -- References -- Chapter 29. Albendazole -- General Information -- Organs and Systems -- Second-Generation Effects -- Drug-Drug Interactions -- References -- Chapter 30. Albumin -- General Information -- Organs and Systems -- Second-Generation Effects -- Drug Administration -- Drug-Drug Interactions -- References -- Chapter 31. Alclofenac -- General Information -- Reference -- Chapter 32. Alcuronium -- General Information -- Organs and Systems -- Second-Generation Effects. , Susceptibility Factors -- Drug-Drug Interactions -- References -- Chapter 33. Aldesleukin -- General Information -- Organs and Systems -- Long-Term Effects -- Drug-Drug Interactions -- References -- Chapter 34. Aldose reductase inhibitors -- General Information -- Organs and Systems -- References -- Chapter 35. Alemtuzumab -- General Information -- Organs and Systems -- References -- Chapter 36. Alfadolone and alfaxolone -- General Information -- Reference -- Chapter 37. Alfentanil -- General Information -- Organs and Systems -- Susceptibility Factors -- Second-Generation Effects -- Drug-Drug Interactions -- References -- Chapter 38. Alfuzosin -- General Information -- Organs and Systems -- References -- Chapter 39. Algae -- General Information -- References -- Chapter 40. Alimemazine -- General Information -- Organs and Systems -- Reference -- Chapter 41. Aliphatic alcohols -- General Information -- Organs and Systems -- Drug Administration -- References -- Chapter 42. Alizapride -- General Information -- Drug-Drug Interactions -- References -- Chapter 43. Alkylating cytostatic agents -nitrosoureas -- General Information -- Organs and Systems -- Long-Term Effects -- Second-Generation Effects -- References -- Chapter 44. Alkylating cytostatic agents -N-lost derivatives -- General Information -- Organs and Systems -- Long-Term Effects -- References -- Chapter 45. Allopurinol -- General Information -- Organs and Systems -- Susceptibility Factors -- Drug-Drug Interactions -- References -- Chapter 46. Almitrine -- General Information -- Organs and Systems -- References -- Chapter 47. Aloeaceae -- General Information -- References -- Chapter 48. Alpha1-antitrypsin -- General Information -- Organs and Systems -- References -- Chapter 49. Alpha-adrenoceptor antagonists -- General Information -- References -- Chapter 50. Alpha-glucosidase inhibitors. , General Information -- Organs and Systems -- Second-Generation Effects -- Drug-Drug Interactions -- References -- Chapter 51. Alphaprodine -- General Information -- Reference -- Chapter 52. Alpidem -- General Information -- References -- Chapter 53. Alprazolam -- General Information -- Organs and Systems -- Long-Term Effects -- Drug-Drug Interactions -- References -- Chapter 54. Alprostadil -- General Information -- Organs and Systems -- References -- Chapter 55. Aluminium -- General Information -- Organs and Systems -- Susceptibility Factors -- Drug Administration -- Drug-Drug Interactions -- References -- Chapter 56. Amantadine -- General Information -- Organs and Systems -- Long-Term Effects -- Susceptibility Factors -- References -- Chapter 57. Amaranthaceae -- General Information -- Reference -- Chapter 58. Amfebutamone (bupropion) -- General Information -- Organs and Systems -- Drug Administration -- Drug-Drug Interactions -- References -- Chapter 59. Amfepramone (diethylpropion) -- General Information -- Organs and Systems -- Long-Term Effects -- Drug-Drug Interactions -- References -- Chapter 60. Amikacin -- General Information -- Organs and Systems -- Long-Term Effects -- Susceptibility Factors -- Drug Administration -- Drug-Drug Interactions -- References -- Chapter 61. Amiloride -- General Information -- Organs and Systems -- Drug-Drug Interactions -- Interference with Diagnostic Tests -- References -- Chapter 62. Amineptine -- General Information -- Organs and Systems -- Long-Term Effects -- References -- Chapter 63. Aminocaproic acid -- General Information -- Organs and Systems -- Susceptibility Factors -- References -- Chapter 64. Aminoglycoside antibiotics -- General Information -- Organs and Systems -- Long-Term Effects -- Susceptibility Factors -- Second-Generation Effects -- Drug Administration -- Drug-Drug Interactions. , Monitoring Therapy -- References -- Chapter 65. Aminophenazone -- General Information -- Organs and Systems -- Long-Term Effects -- Drug Administration -- References -- Chapter 66. Aminorex -- General Information -- Organs and Systems -- References -- Chapter 67. Aminosalicylates -- General Information -- Organs and Systems -- Second-Generation Effects -- Susceptibility Factors -- Drug Administration -- Drug-Drug Interactions -- Interference with Diagnostic Tests -- References -- Chapter 68. Amiodarone -- General Information -- Chapter 69. Organs and Systems -- Second-Generation Effects -- Susceptibility Factors -- Drug Administration -- Drug-Drug Interactions -- Interference with Diagnostic Tests -- Diagnosis of Adverse Drug Reactions -- References -- Chapter 70. Amiphenazole -- General Information -- References -- Chapter 71. Amisulpride -- General Information -- Organs and Systems -- References -- Chapter 72. Amitriptylinoxide -- General Information -- Reference -- Chapter 73. Amlodipine -- General Information -- Organs and Systems -- Drug Administration -- Second-Generation Effects -- Drug-Drug Interactions -- References -- Chapter 74. Ammonium chloride -- General Information -- Reference -- Chapter 75. Ammonium tetrathiomolybdate -- General Information -- Organs and Systems -- References -- Chapter 76. Amocarzine -- General Information -- References -- Chapter 77. Amodiaquine -- General Information -- Organs and Systems -- Reference -- Chapter 78. Amopyroquine -- General Information -- Reference -- Chapter 79. Amoxapine -- General Information -- Organs and Systems -- Drug Administration -- References -- Chapter 80. Amphetamines -- General Information -- Organs and Systems -- Long-Term Effects -- Second-Generation Effects -- Susceptibility Factors -- Drug Administration -- Drug-Drug Interactions -- References -- Chapter 81. Amphotericin. , General Information.

Note: Intro -- ENERGY METABOLISM IN TRAUMA -- Contents -- The acute effects of trauma on heat production -- Discussion -- Changes in energy metabolism during recovery from injury -- Discussion -- General discussion -- The protein component ofthe disturbance of energy metabolism in trauma -- Discussion -- Protein catabolism and energy utilization in burned patients treated at different environmental temperatures -- Discussion -- Synthesis and turnover of acute-phase reactants -- Discussion -- General discussion -- Carbohydrate and nitrogen metabolism after injury -- Discussion -- Intermediary carbohydrate metabolism in injured rat liver in relation to heat production -- Discussion -- Effects of E. coli lipopolysaccharide B treatment of rats on gluconeogenesis -- Discussion -- Mobilization and utilization of lipids after trauma: relation to caloric homeostasis -- Discussion -- Ketone body metabolism after trauma -- Discussion -- General discussion -- Author Index -- Subject Index.